Propel Bio Management »

Eiger Biopharmaceuticals shares owned by Propel Bio Management

Quarter-by-quarter ownership of Eiger Biopharmaceuticals shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Eiger Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eiger Biopharmaceuticals held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eiger Biopharmaceuticals by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.9M 146k 12.65
2024-03-31 $732k 146k 5.00

More positions owned by Propel Bio Management

Applied Therapeutics Comm (APLT)
Plains Gp Holdings Lp-cl Comm (PAGP)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Achieve Life Sciences Comm (ACHV)
Phathom Pharmaceuticals I Comm (PHAT)
Akero Therapeutics Comm (AKRO)
Avidity Biosciences Comm (RNA)
Ardelyx Comm (ARDX)
Abeona Therapeutics Comm (ABEO)
Fulcrum Therapeutics Comm (FULC)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Verrica Pharmaceuticals I Comm (VRCA)
Kura Oncology Comm (KURA)

View all positions for Propel Bio Management

Top funds holding Eiger Biopharmaceuticals

Propel Bio Management

View all funds holding Eiger Biopharmaceuticals